BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 31402430)

  • 1. CRISPR/Cas9-mediated Knockout of the Neuropsychiatric Risk Gene KCTD13 Causes Developmental Deficits in Human Cortical Neurons Derived from Induced Pluripotent Stem Cells.
    Kizner V; Naujock M; Fischer S; Jäger S; Reich S; Schlotthauer I; Zuckschwerdt K; Geiger T; Hildebrandt T; Lawless N; Macartney T; Dorner-Ciossek C; Gillardon F
    Mol Neurobiol; 2020 Feb; 57(2):616-634. PubMed ID: 31402430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the RHOA pathway improves learning and memory in adult Kctd13 and 16p11.2 deletion mouse models.
    Martin Lorenzo S; Nalesso V; Chevalier C; Birling MC; Herault Y
    Mol Autism; 2021 Jan; 12(1):1. PubMed ID: 33436060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss-of-function Mutations of CUL3, a High Confidence Gene for Psychiatric Disorders, Lead to Aberrant Neurodevelopment In Human Induced Pluripotent Stem Cells.
    Fischer S; Schlotthauer I; Kizner V; Macartney T; Dorner-Ciossek C; Gillardon F
    Neuroscience; 2020 Nov; 448():234-254. PubMed ID: 32890664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 16p11.2 deletion is associated with hyperactivation of human iPSC-derived dopaminergic neuron networks and is rescued by RHOA inhibition in vitro.
    Sundberg M; Pinson H; Smith RS; Winden KD; Venugopal P; Tai DJC; Gusella JF; Talkowski ME; Walsh CA; Tegmark M; Sahin M
    Nat Commun; 2021 May; 12(1):2897. PubMed ID: 34006844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatiotemporal 16p11.2 protein network implicates cortical late mid-fetal brain development and KCTD13-Cul3-RhoA pathway in psychiatric diseases.
    Lin GN; Corominas R; Lemmens I; Yang X; Tavernier J; Hill DE; Vidal M; Sebat J; Iakoucheva LM
    Neuron; 2015 Feb; 85(4):742-54. PubMed ID: 25695269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Rapid Pipeline to Model Rare Neurodevelopmental Disorders with Simultaneous CRISPR/Cas9 Gene Editing.
    Bell S; Peng H; Crapper L; Kolobova I; Maussion G; Vasuta C; Yerko V; Wong TP; Ernst C
    Stem Cells Transl Med; 2017 Mar; 6(3):886-896. PubMed ID: 28170165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kctd13 deletion reduces synaptic transmission via increased RhoA.
    Escamilla CO; Filonova I; Walker AK; Xuan ZX; Holehonnur R; Espinosa F; Liu S; Thyme SB; López-García IA; Mendoza DB; Usui N; Ellegood J; Eisch AJ; Konopka G; Lerch JP; Schier AF; Speed HE; Powell CM
    Nature; 2017 Nov; 551(7679):227-231. PubMed ID: 29088697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted gene therapy in human-induced pluripotent stem cells from a patient with primary hyperoxaluria type 1 using CRISPR/Cas9 technology.
    Estève J; Blouin JM; Lalanne M; Azzi-Martin L; Dubus P; Bidet A; Harambat J; Llanas B; Moranvillier I; Bedel A; Moreau-Gaudry F; Richard E
    Biochem Biophys Res Commun; 2019 Oct; 517(4):677-683. PubMed ID: 31402115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders.
    Prem S; Millonig JH; DiCicco-Bloom E
    Adv Neurobiol; 2020; 25():109-153. PubMed ID: 32578146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in cerebral organoids derived from iPS cells.
    Wang P; Mokhtari R; Pedrosa E; Kirschenbaum M; Bayrak C; Zheng D; Lachman HM
    Mol Autism; 2017; 8():11. PubMed ID: 28321286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient manipulation of gene dosage in human iPSCs using CRISPR/Cas9 nickases.
    Ye T; Duan Y; Tsang HWS; Xu H; Chen Y; Cao H; Chen Y; Fu AKY; Ip NY
    Commun Biol; 2021 Feb; 4(1):195. PubMed ID: 33580208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant.
    Golzio C; Willer J; Talkowski ME; Oh EC; Taniguchi Y; Jacquemont S; Reymond A; Sun M; Sawa A; Gusella JF; Kamiya A; Beckmann JS; Katsanis N
    Nature; 2012 May; 485(7398):363-7. PubMed ID: 22596160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal Differentiation of Induced Pluripotent Stem Cells from Schizophrenia Patients in Two-Dimensional and in Three-Dimensional Cultures Reveals Increased Expression of the Kv4.2 Subunit DPP6 That Contributes to Decreased Neuronal Activity.
    Naujock M; Speidel A; Fischer S; Kizner V; Dorner-Ciossek C; Gillardon F
    Stem Cells Dev; 2020 Dec; 29(24):1577-1587. PubMed ID: 33143549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency in MT5-MMP Supports Branching of Human iPSCs-Derived Neurons and Reduces Expression of GLAST/S100 in iPSCs-Derived Astrocytes.
    Arnst N; Belio-Mairal P; García-González L; Arnaud L; Greetham L; Nivet E; Rivera S; Dityatev A
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excitatory Dysfunction Drives Network and Calcium Handling Deficits in 16p11.2 Duplication Schizophrenia Induced Pluripotent Stem Cell-Derived Neurons.
    Parnell E; Culotta L; Forrest MP; Jalloul HA; Eckman BL; Loizzo DD; Horan KKE; Dos Santos M; Piguel NH; Tai DJC; Zhang H; Gertler TS; Simkin D; Sanders AR; Talkowski ME; Gejman PV; Kiskinis E; Duan J; Penzes P
    Biol Psychiatry; 2023 Jul; 94(2):153-163. PubMed ID: 36581494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro models for ASD-patient-derived iPSCs and cerebral organoids.
    Hohmann SS; Ilieva M; Michel TM
    Prog Mol Biol Transl Sci; 2020; 173():355-375. PubMed ID: 32711817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and molecular characterization of multiplex autism in human induced pluripotent stem cell-derived neurons.
    Lewis EMA; Meganathan K; Baldridge D; Gontarz P; Zhang B; Bonni A; Constantino JN; Kroll KL
    Mol Autism; 2019; 10():51. PubMed ID: 31893020
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Llamosas N; Arora V; Vij R; Kilinc M; Bijoch L; Rojas C; Reich A; Sridharan B; Willems E; Piper DR; Scampavia L; Spicer TP; Miller CA; Holder JL; Rumbaugh G
    J Neurosci; 2020 Oct; 40(41):7980-7994. PubMed ID: 32887745
    [No Abstract]   [Full Text] [Related]  

  • 19. Induced pluripotent stem cells as a tool to study brain circuits in autism-related disorders.
    Vitrac A; Cloëz-Tayarani I
    Stem Cell Res Ther; 2018 Aug; 9(1):226. PubMed ID: 30139379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9 and piggyBac-mediated footprint-free LRRK2-G2019S knock-in reveals neuronal complexity phenotypes and α-Synuclein modulation in dopaminergic neurons.
    Qing X; Walter J; Jarazo J; Arias-Fuenzalida J; Hillje AL; Schwamborn JC
    Stem Cell Res; 2017 Oct; 24():44-50. PubMed ID: 28826027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.